Medications for treating dystrophic epidermolysis bullosa (DEB) are used to manage skin blistering, promote wound healing, and reduce pain. They work by targeting the underlying genetic issues or by providing supportive care to the skin. Gene therapies like Vyjuvek (beremagene geperpavec) are applied topically to the skin to treat this condition.